Breaking New Ground in
the Treatment of Fibrosis.
Breakthroughs in targeted integrin therapies are on the horizon.
At Pliant, our commitment is to bring hope to patients with fibrosis through the discovery and development of therapies for fibrotic diseases.
Our focus is to better understand the molecular drivers of fibrotic diseases and to unlock potentially safer and more effective therapies for patients.
Our Pipeline
Our highly experienced drug development team is focused on claiming new territory in tissue-specific therapies. Pliant’s pipeline includes integrin-based programs that emerged from our proprietary discovery platform.
Latest News
05-21-2025
Careers & Culture
We are passionate about delivering breakthrough therapies to patients. Hear our Plianteers share what makes Pliant such an inspiring and exciting place to work.
